Rohto Pharmaceutical Coltd Stock Net Income
| RPHCFDelisted Stock | USD 14.72 0.00 0.00% |
As of the 11th of February 2026, Rohto Pharmaceutical holds the Coefficient Of Variation of (231.38), variance of 146.83, and Risk Adjusted Performance of (0.34). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rohto Pharmaceutical, as well as the relationship between them. Please check Rohto Pharmaceutical standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Rohto Pharmaceutical is priced some-what accurately, providing market reflects its current price of 14.72 per share. Given that Rohto Pharmaceutical has information ratio of (0.44), we recommend you to check out Rohto Pharmaceutical's recent market performance to make sure the company can sustain itself at a future point.
Rohto Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Rohto Pharmaceutical's valuation are provided below:Rohto Pharmaceutical CoLtd does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Rohto |
Search Suggestions
| R | Ryder System | Company |
| RF-PC | Regions Financial | Company |
| RCS | Pimco Strategic Income | Fund |
| RB | ProShares Trust | ETF |
| RCI | Dow Jones Composite | Index |
| RSR | RSR | Cryptocurrency |
| R9900CAT3 | YARNO 7378 14 NOV 32 | Corporate Bond |
| RBUSD | Gasoline RBOB | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Rohto Pharmaceutical CoLtd reported net income of 21.02 B. This is much higher than that of the Consumer Defensive sector and significantly higher than that of the Household & Personal Products industry. The net income for all United States stocks is significantly lower than that of the firm.
Rohto Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rohto Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rohto Pharmaceutical could also be used in its relative valuation, which is a method of valuing Rohto Pharmaceutical by comparing valuation metrics of similar companies.Rohto Pharmaceutical is currently under evaluation in net income category among its peers.
Rohto Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0696 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 3.27 B | |||
| Shares Outstanding | 228.14 M | |||
| Shares Owned By Insiders | 13.39 % | |||
| Shares Owned By Institutions | 40.41 % | |||
| Price To Earning | 25.85 X | |||
| Price To Book | 2.57 X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 199.65 B | |||
| Gross Profit | 116.49 B | |||
| EBITDA | 35.87 B | |||
| Net Income | 21.02 B | |||
| Cash And Equivalents | 77.26 B | |||
| Cash Per Share | 677.27 X | |||
| Total Debt | 13.35 B | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 2.27 X | |||
| Book Value Per Share | 877.16 X | |||
| Cash Flow From Operations | 27.25 B | |||
| Earnings Per Share | 0.77 X | |||
| Number Of Employees | 6.87 K | |||
| Beta | 0.14 | |||
| Market Capitalization | 4.15 B | |||
| Total Asset | 274.63 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 274.63 B | |||
| Last Dividend Paid | 10.5 |
About Rohto Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rohto Pharmaceutical CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rohto Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rohto Pharmaceutical CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Rohto Pink Sheet
If you are still planning to invest in Rohto Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rohto Pharmaceutical's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |